Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with one observation. The inspection was carried out from 15th September, 2019 to 20th September, 2019.
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.518.5 as compared to the previous close of Rs. 511.7. The total number of shares traded during the day was 3088 in over 218 trades.
The stock hit an intraday high of Rs. 521.5 and intraday low of 514. The net turnover during the day was Rs. 1599985.